Cargando…

Identification of proteins and signalling pathways involved in neoadjuvant chemotherapy responsiveness of breast tumours using proteomics

Detalles Bibliográficos
Autores principales:	Greenwood, CR, Alldridge, LC, Sekharan, S Chandra, Al-Janabi, K, Sauven, P, Souchelnytskyi, S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875602/ http://dx.doi.org/10.1186/bcr2537

Ejemplares similares

Optimized Protocol for Protein Extraction from the Breast Tissue that is Compatible with Two-Dimensional Gel Electrophoresis
por: Zakharchenko, Olena, et al.
Publicado: (2011)

Does imaging correctly influence the surgical management in the setting of neoadjuvant chemotherapy?
por: Fatayer, H, et al.
Publicado: (2012)

Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010)

PB.34. Marker clip placement may not be needed in breast cancer patients undergoing neoadjuvant chemotherapy with a view to breast-conserving surgery whose tumours are associated with microcalcification
por: Sreenivas, M
Publicado: (2014)

Correlation of post-neoadjuvant chemotherapy response on MRI with final histology in breast cancer patients
por: Mahatma, Anjum, et al.
Publicado: (2015)

Identification of genes involved in the formation of lymph node metastasis from human tumour xenograft models of breast cancer
por: Paon, L, et al.
Publicado: (2008)

PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
por: Halim, M, et al.
Publicado: (2014)

Comparing extended and standard lymphadenectomy surgeries for bladder cancer (complications, final outcomes and effects of neoadjuvant chemotherapy)
por: Thiara, GS, et al.
Publicado: (2015)

Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers
por: Attarha, S, et al.
Publicado: (2013)

Imaging the breast following neoadjuvant chemotherapy: does improvement of imaging findings in the axilla predict pathological response in the breast?
por: Williams, A, et al.
Publicado: (2012)

Identification and proteomic analysis of petroleum degrading bacteria
por: Souza-Neto, Júlio Nino, et al.
Publicado: (2014)

Use of MRI to predict response following neoadjuvant chemotherapy for breast cancer: how accurately can it guide surgical choice?
por: Tan, Sue, et al.
Publicado: (2015)

PB.40. What happens to the ductal carcinoma in situ in HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?
por: Millican-Slater, R, et al.
Publicado: (2014)

Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
por: Islam, S, et al.
Publicado: (2015)

Identification of molecular apocrine breast tumours by microarray analysis
por: Farmer, P, et al.
Publicado: (2005)

Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy
por: Friedberg, T, et al.
Publicado: (2006)

Enabling proteomics-based identification of human cancer variations
por: Li, Jing, et al.
Publicado: (2010)

Use of ultrasound elasticity imaging to monitor the response of a primary breast cancer to neoadjuvant chemotherapy in one patient in a pilot study
por: English, RE, et al.
Publicado: (2011)

Chemotherapy-induced modulation of [(18)F]Fluoro-2-deoxy-D-glucose incorporation at the tumour cell level
por: Sharma, RI, et al.
Publicado: (2008)

Phylloides tumours: review of 42 cases
por: Chandrasekharan, S, et al.
Publicado: (2002)

Indications for marker clip in the setting of neoadjuvant/neoendocrine therapy
por: Fletcher, ME, et al.
Publicado: (2012)

Identification of molecular subtypes within a formalin-fixed, paraffin-embedded breast cancer tumour cohort
por: Mulligan, JM, et al.
Publicado: (2010)

Characterization of the Plasmodium vivax erythrocytic stage proteome and identification of a potent immunogenic antigen of the asexual stages
por: Roobsoong, Wanlapa, et al.
Publicado: (2010)

Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)

The challenges of using radiological ‘tumour response' as an outcome: lessons learned from neo-tango and artemis, two neo-adjuvant chemotherapy breast cancer trials
por: Hiller, Louise, et al.
Publicado: (2013)

Identification of proteins associated with radiotherapy resistance in breast cancer cells: a combined proteomic and microarray screening approach
por: Smith, L, et al.
Publicado: (2008)

Postoperative serum proteomic profiles and identification of biomarkers with prognosis value in high-risk early breast cancer patients
por: Gonçalves, A, et al.
Publicado: (2005)

To assess the clinical usefulness of radio-opaque marker insertion into malignant breast tumours in patients undergoing neo-adjuvant chemotherapy prior to consideration of breast-conserving surgery
por: Evans, SE, et al.
Publicado: (2006)

Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
por: Schokraie, Elham, et al.
Publicado: (2013)

Feasibility of stored red blood cell transfusion in pigs
por: Azevedo, LCP, et al.
Publicado: (2009)

Identification and characterization of novel NF-kB dependent genes involved in HTLV-I pathogenesis
por: Qu, Zhaoxia, et al.
Publicado: (2015)

Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam
por: Ngatoluwa, M, et al.
Publicado: (2012)

Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
por: Lehn, S, et al.
Publicado: (2009)

Three dimensional organisation of basal bodies in Trypanosoma brucei
por: Towers, K, et al.
Publicado: (2012)

A proteomic study of sepsis
por: Soares, A, et al.
Publicado: (2005)

CYLD tumour supressor regulates ciligenesis
por: Eguether, T, et al.
Publicado: (2012)

“BLUE BOARD” – an innovative knowledge management programme for educating health care practioners using blended learning modules
por: Parathasarathy, CR
Publicado: (2011)

Shotgun proteomics reveals biochemistry of normal and acute respiratory distress syndrome bronchoalveolar lavage fluid proteome
por: Goodlett, D
Publicado: (2008)

Identification of a new variant of TTR involved in familial amyloid cardiomyopathy (FAC) in Brazil: from the patient to the protein
por: Ferreira, Priscila, et al.
Publicado: (2015)

Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
por: Løkkegaard, S, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_97ppr1g44ecgv1b35135cd78u9